A review of safe and effective pharmacotherapies for Pediatric and neonatal septic shock

Area of Science:

• Pediatric critical care medicine
• Infectious diseases
• Neonatology

Background:

• Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
• Pediatric septic shock, a severe form, significantly contributes to global child morbidity and mortality.
• Despite its impact, management strategies for pediatric septic shock have seen limited evolution over two decades.

Purpose of the Study:

• To review current management paradigms for neonatal and pediatric septic shock.
• To highlight advancements in diagnosis and treatment, including adjunctive therapies.
• To discuss the impact of evidence-based initiatives like the Surviving Sepsis Campaign.

Main Methods:

• A comprehensive literature search was performed using PubMed and Embase.
• Key search terms included 'Paediatric,' 'sepsis,' 'shock,' 'neonatal,' 'antimicrobial,' and 'adjunctive therapy.'
• The search covered literature from 1965 to the present date.

Main Results:

• The core management of pediatric septic shock relies on rapid recognition, timely antibiotic and fluid therapy, and supportive care.
• The implementation of 'bundles of care' has demonstrably improved patient outcomes.
• Molecular diagnostics have enhanced antimicrobial stewardship, though novel adjunctive therapies are still emerging.

Conclusions:

• While foundational treatments persist, the integration of care bundles represents a significant advancement in managing pediatric septic shock.
• Continued research into novel adjunctive therapies holds promise for future treatment improvements.
• Evidence-based practices, guided by initiatives like the Surviving Sepsis Campaign, are crucial for optimizing outcomes.